[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fr_V9LzbueQ2QIJQu9YMJSevvHaGx-s4LtKdgZroWKx0":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":35,"phaseBuckets":41,"rows":48},"MetroHealth Medical Center",[4],103,false,22,1,9898,81,[13,16,19,21,24,27,30,32],{"name":14,"count":15},"Stroke",17,{"name":17,"count":18},"Hemiplegia",7,{"name":20,"count":18},"Spinal Cord Injuries",{"name":22,"count":23},"Hemiparesis",6,{"name":25,"count":26},"Shoulder Pain",5,{"name":28,"count":29},"Obstructive Sleep Apnea",4,{"name":31,"count":29},"Paralysis",{"name":33,"count":34},"Gait, Hemiplegic",3,[36],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT05302999","Feasibility of Early Gabapentin as an Intervention for Neurorecovery","2026-08-31","Gabapentin",[42,43,44,45,46,47],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[49,84,110,137,155,181,199,228,246,264,282,300,318,343,370,398,423,441,469,487,505,532,550,575,593,617,642,666,691,721,739,757,775,802,827,851],{"intervention":40,"totalTrials":50,"cells":51},2,{"EARLY_PHASE1":52,"PHASE1":55,"PHASE2":57,"PHASE3":59,"PHASE4":61,"NA":82},{"trials":53,"activeCount":54},[],0,{"trials":56,"activeCount":54},[],{"trials":58,"activeCount":54},[],{"trials":60,"activeCount":54},[],{"trials":62,"activeCount":9,"soonestReadout":39},[63,70],{"nctId":37,"briefTitle":38,"status":64,"phases":65,"primaryCompletion":39,"completion":39,"start":66,"enrollment":67,"conditions":68,"interventions":69},"RECRUITING",[46],"2022-03-14",42,[20],[40],{"nctId":71,"briefTitle":72,"status":73,"phases":74,"primaryCompletion":75,"completion":76,"start":77,"enrollment":78,"conditions":79,"interventions":81},"NCT04256603","Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI","COMPLETED",[46],"2020-03-30","2020-04-01","2019-08-01",27,[20,80],"Neuropathic Pain",[40],{"trials":83,"activeCount":54},[],{"intervention":85,"totalTrials":9,"cells":86},"Fluoxetine",{"EARLY_PHASE1":87,"PHASE1":89,"PHASE2":91,"PHASE3":93,"PHASE4":95,"NA":108},{"trials":88,"activeCount":54},[],{"trials":90,"activeCount":54},[],{"trials":92,"activeCount":54},[],{"trials":94,"activeCount":54},[],{"trials":96,"activeCount":54},[97],{"nctId":98,"briefTitle":99,"status":73,"phases":100,"primaryCompletion":101,"completion":101,"start":102,"enrollment":103,"conditions":104,"interventions":107},"NCT03390933","Identifying and Treating Depression in Hemodialysis Patients",[46],"2023-02-28","2018-03-01",16,[105,106],"Depression","Hemodialysis-Induced Symptom",[85],{"trials":109,"activeCount":54},[],{"intervention":111,"totalTrials":9,"cells":112},"Pentoxifylline",{"EARLY_PHASE1":113,"PHASE1":115,"PHASE2":117,"PHASE3":119,"PHASE4":121,"NA":135},{"trials":114,"activeCount":54},[],{"trials":116,"activeCount":54},[],{"trials":118,"activeCount":54},[],{"trials":120,"activeCount":54},[],{"trials":122,"activeCount":54},[123],{"nctId":124,"briefTitle":125,"status":126,"phases":127,"primaryCompletion":128,"completion":129,"start":130,"enrollment":54,"conditions":131,"interventions":133},"NCT03859570","Pentoxifylline in Lupus Nephritis","WITHDRAWN",[46],"2021-12","2022-12","2020-09-01",[132],"Lupus Nephritis",[111,134],"Placebos",{"trials":136,"activeCount":54},[],{"intervention":134,"totalTrials":9,"cells":138},{"EARLY_PHASE1":139,"PHASE1":141,"PHASE2":143,"PHASE3":145,"PHASE4":147,"NA":153},{"trials":140,"activeCount":54},[],{"trials":142,"activeCount":54},[],{"trials":144,"activeCount":54},[],{"trials":146,"activeCount":54},[],{"trials":148,"activeCount":54},[149],{"nctId":124,"briefTitle":125,"status":126,"phases":150,"primaryCompletion":128,"completion":129,"start":130,"enrollment":54,"conditions":151,"interventions":152},[46],[132],[111,134],{"trials":154,"activeCount":54},[],{"intervention":156,"totalTrials":9,"cells":157},"Cystoscopic Fluid containing Neosporin G. U. Irrigant",{"EARLY_PHASE1":158,"PHASE1":160,"PHASE2":162,"PHASE3":164,"PHASE4":166,"NA":179},{"trials":159,"activeCount":54},[],{"trials":161,"activeCount":54},[],{"trials":163,"activeCount":54},[],{"trials":165,"activeCount":54},[],{"trials":167,"activeCount":54},[168],{"nctId":169,"briefTitle":170,"status":73,"phases":171,"primaryCompletion":172,"completion":172,"start":173,"enrollment":174,"conditions":175,"interventions":177},"NCT03099863","Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection",[46],"2020-06","2016-04",242,[176],"Urinary Tract Infections",[156,178],"Cystoscopic Fluid\u002FPlacebo",{"trials":180,"activeCount":54},[],{"intervention":178,"totalTrials":9,"cells":182},{"EARLY_PHASE1":183,"PHASE1":185,"PHASE2":187,"PHASE3":189,"PHASE4":191,"NA":197},{"trials":184,"activeCount":54},[],{"trials":186,"activeCount":54},[],{"trials":188,"activeCount":54},[],{"trials":190,"activeCount":54},[],{"trials":192,"activeCount":54},[193],{"nctId":169,"briefTitle":170,"status":73,"phases":194,"primaryCompletion":172,"completion":172,"start":173,"enrollment":174,"conditions":195,"interventions":196},[46],[176],[156,178],{"trials":198,"activeCount":54},[],{"intervention":200,"totalTrials":9,"cells":201},"Ketorolac",{"EARLY_PHASE1":202,"PHASE1":204,"PHASE2":206,"PHASE3":208,"PHASE4":210,"NA":226},{"trials":203,"activeCount":54},[],{"trials":205,"activeCount":54},[],{"trials":207,"activeCount":54},[],{"trials":209,"activeCount":54},[],{"trials":211,"activeCount":54},[212],{"nctId":213,"briefTitle":214,"status":73,"phases":215,"primaryCompletion":216,"completion":216,"start":77,"enrollment":217,"conditions":218,"interventions":220},"NCT03987022","ICE-T Pain Regimen for Total Laparoscopic Hysterectomy",[46],"2022-04-25",66,[219],"Opioid Substitution Treatment",[200,221,222,223,224,225],"Opioids","Tylenol","Motrin","Dilaudid Injectable Product","Percocet 5Mg-325Mg",{"trials":227,"activeCount":54},[],{"intervention":221,"totalTrials":9,"cells":229},{"EARLY_PHASE1":230,"PHASE1":232,"PHASE2":234,"PHASE3":236,"PHASE4":238,"NA":244},{"trials":231,"activeCount":54},[],{"trials":233,"activeCount":54},[],{"trials":235,"activeCount":54},[],{"trials":237,"activeCount":54},[],{"trials":239,"activeCount":54},[240],{"nctId":213,"briefTitle":214,"status":73,"phases":241,"primaryCompletion":216,"completion":216,"start":77,"enrollment":217,"conditions":242,"interventions":243},[46],[219],[200,221,222,223,224,225],{"trials":245,"activeCount":54},[],{"intervention":222,"totalTrials":9,"cells":247},{"EARLY_PHASE1":248,"PHASE1":250,"PHASE2":252,"PHASE3":254,"PHASE4":256,"NA":262},{"trials":249,"activeCount":54},[],{"trials":251,"activeCount":54},[],{"trials":253,"activeCount":54},[],{"trials":255,"activeCount":54},[],{"trials":257,"activeCount":54},[258],{"nctId":213,"briefTitle":214,"status":73,"phases":259,"primaryCompletion":216,"completion":216,"start":77,"enrollment":217,"conditions":260,"interventions":261},[46],[219],[200,221,222,223,224,225],{"trials":263,"activeCount":54},[],{"intervention":223,"totalTrials":9,"cells":265},{"EARLY_PHASE1":266,"PHASE1":268,"PHASE2":270,"PHASE3":272,"PHASE4":274,"NA":280},{"trials":267,"activeCount":54},[],{"trials":269,"activeCount":54},[],{"trials":271,"activeCount":54},[],{"trials":273,"activeCount":54},[],{"trials":275,"activeCount":54},[276],{"nctId":213,"briefTitle":214,"status":73,"phases":277,"primaryCompletion":216,"completion":216,"start":77,"enrollment":217,"conditions":278,"interventions":279},[46],[219],[200,221,222,223,224,225],{"trials":281,"activeCount":54},[],{"intervention":224,"totalTrials":9,"cells":283},{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":298},{"trials":285,"activeCount":54},[],{"trials":287,"activeCount":54},[],{"trials":289,"activeCount":54},[],{"trials":291,"activeCount":54},[],{"trials":293,"activeCount":54},[294],{"nctId":213,"briefTitle":214,"status":73,"phases":295,"primaryCompletion":216,"completion":216,"start":77,"enrollment":217,"conditions":296,"interventions":297},[46],[219],[200,221,222,223,224,225],{"trials":299,"activeCount":54},[],{"intervention":225,"totalTrials":9,"cells":301},{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":316},{"trials":303,"activeCount":54},[],{"trials":305,"activeCount":54},[],{"trials":307,"activeCount":54},[],{"trials":309,"activeCount":54},[],{"trials":311,"activeCount":54},[312],{"nctId":213,"briefTitle":214,"status":73,"phases":313,"primaryCompletion":216,"completion":216,"start":77,"enrollment":217,"conditions":314,"interventions":315},[46],[219],[200,221,222,223,224,225],{"trials":317,"activeCount":54},[],{"intervention":319,"totalTrials":9,"cells":320},"Optimal Dosing of Omeprazole",{"EARLY_PHASE1":321,"PHASE1":323,"PHASE2":325,"PHASE3":327,"PHASE4":329,"NA":341},{"trials":322,"activeCount":54},[],{"trials":324,"activeCount":54},[],{"trials":326,"activeCount":54},[],{"trials":328,"activeCount":54},[],{"trials":330,"activeCount":54},[331],{"nctId":332,"briefTitle":333,"status":73,"phases":334,"primaryCompletion":335,"completion":335,"start":336,"enrollment":337,"conditions":338,"interventions":340},"NCT02623816","Symptom Control Satisfaction With Proton Pump Inhibitor Regimen",[46],"2015-12","2014-08",64,[339],"Heartburn",[319],{"trials":342,"activeCount":54},[],{"intervention":344,"totalTrials":9,"cells":345},"sildenafil",{"EARLY_PHASE1":346,"PHASE1":348,"PHASE2":350,"PHASE3":352,"PHASE4":354,"NA":368},{"trials":347,"activeCount":54},[],{"trials":349,"activeCount":54},[],{"trials":351,"activeCount":54},[],{"trials":353,"activeCount":54},[],{"trials":355,"activeCount":54},[356],{"nctId":357,"briefTitle":358,"status":73,"phases":359,"primaryCompletion":360,"completion":361,"start":362,"enrollment":363,"conditions":364,"interventions":367},"NCT00781508","Effects of Viagra on Heart Function in Patients With Heart Failure",[46],"2009-09","2009-11","2006-12",10,[365,366],"Heart Failure","Left Ventricular Dysfunction",[344],{"trials":369,"activeCount":54},[],{"intervention":371,"totalTrials":9,"cells":372},"Rifaximin",{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":379,"PHASE4":394,"NA":396},{"trials":374,"activeCount":54},[],{"trials":376,"activeCount":54},[],{"trials":378,"activeCount":54},[],{"trials":380,"activeCount":54},[381],{"nctId":382,"briefTitle":383,"status":126,"phases":384,"primaryCompletion":385,"completion":386,"start":387,"enrollment":54,"conditions":388,"interventions":393},"NCT04244877","Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility",[45],"2023-05-01","2023-12-01","2021-09-15",[389,390,391,392],"Cirrhosis, Liver","Minimal Hepatic Encephalopathy","Small Intestinal Bacterial Overgrowth","Gastrointestinal Motility Disorder",[371],{"trials":395,"activeCount":54},[],{"trials":397,"activeCount":54},[],{"intervention":399,"totalTrials":9,"cells":400},"Lidocaine",{"EARLY_PHASE1":401,"PHASE1":403,"PHASE2":405,"PHASE3":417,"PHASE4":419,"NA":421},{"trials":402,"activeCount":54},[],{"trials":404,"activeCount":54},[],{"trials":406,"activeCount":54},[407],{"nctId":408,"briefTitle":409,"status":73,"phases":410,"primaryCompletion":411,"completion":411,"start":412,"enrollment":413,"conditions":414,"interventions":415},"NCT00597766","Subacromial Corticosteroid Injection for Hemiplegic Shoulder Pain",[44],"2012-02","2007-12",28,[25],[399,416,416,416],"Triamcinolone + Lidocaine",{"trials":418,"activeCount":54},[],{"trials":420,"activeCount":54},[],{"trials":422,"activeCount":54},[],{"intervention":416,"totalTrials":9,"cells":424},{"EARLY_PHASE1":425,"PHASE1":427,"PHASE2":429,"PHASE3":435,"PHASE4":437,"NA":439},{"trials":426,"activeCount":54},[],{"trials":428,"activeCount":54},[],{"trials":430,"activeCount":54},[431],{"nctId":408,"briefTitle":409,"status":73,"phases":432,"primaryCompletion":411,"completion":411,"start":412,"enrollment":413,"conditions":433,"interventions":434},[44],[25],[399,416,416,416],{"trials":436,"activeCount":54},[],{"trials":438,"activeCount":54},[],{"trials":440,"activeCount":54},[],{"intervention":442,"totalTrials":9,"cells":443},"2 million hMSC\u002Fkg",{"EARLY_PHASE1":444,"PHASE1":446,"PHASE2":461,"PHASE3":463,"PHASE4":465,"NA":467},{"trials":445,"activeCount":54},[],{"trials":447,"activeCount":54},[448],{"nctId":449,"briefTitle":450,"status":451,"phases":452,"primaryCompletion":453,"completion":454,"start":455,"enrollment":363,"conditions":456,"interventions":458},"NCT03186417","Mesenchymal Stem Cells in Early Rheumatoid Arthritis","TERMINATED",[43],"2023-04-30","2023-05-31","2017-12-15",[457],"Rheumatoid Arthritis",[442,459,460],"4 million hMSC\u002Fkg","6 million hMSC\u002Fkg",{"trials":462,"activeCount":54},[],{"trials":464,"activeCount":54},[],{"trials":466,"activeCount":54},[],{"trials":468,"activeCount":54},[],{"intervention":459,"totalTrials":9,"cells":470},{"EARLY_PHASE1":471,"PHASE1":473,"PHASE2":479,"PHASE3":481,"PHASE4":483,"NA":485},{"trials":472,"activeCount":54},[],{"trials":474,"activeCount":54},[475],{"nctId":449,"briefTitle":450,"status":451,"phases":476,"primaryCompletion":453,"completion":454,"start":455,"enrollment":363,"conditions":477,"interventions":478},[43],[457],[442,459,460],{"trials":480,"activeCount":54},[],{"trials":482,"activeCount":54},[],{"trials":484,"activeCount":54},[],{"trials":486,"activeCount":54},[],{"intervention":460,"totalTrials":9,"cells":488},{"EARLY_PHASE1":489,"PHASE1":491,"PHASE2":497,"PHASE3":499,"PHASE4":501,"NA":503},{"trials":490,"activeCount":54},[],{"trials":492,"activeCount":54},[493],{"nctId":449,"briefTitle":450,"status":451,"phases":494,"primaryCompletion":453,"completion":454,"start":455,"enrollment":363,"conditions":495,"interventions":496},[43],[457],[442,459,460],{"trials":498,"activeCount":54},[],{"trials":500,"activeCount":54},[],{"trials":502,"activeCount":54},[],{"trials":504,"activeCount":54},[],{"intervention":506,"totalTrials":9,"cells":507},"Non-narcotic group regimen",{"EARLY_PHASE1":508,"PHASE1":510,"PHASE2":524,"PHASE3":526,"PHASE4":528,"NA":530},{"trials":509,"activeCount":54},[],{"trials":511,"activeCount":54},[512],{"nctId":513,"briefTitle":514,"status":73,"phases":515,"primaryCompletion":516,"completion":516,"start":517,"enrollment":518,"conditions":519,"interventions":522},"NCT03640247","Pain Medications Following Thyroidectomy and Parathyroidectomy",[43],"2019-12-01","2018-11-15",126,[520,521],"Thyroid Disease","Parathyroid Diseases",[506,523],"Narcotic group regimen",{"trials":525,"activeCount":54},[],{"trials":527,"activeCount":54},[],{"trials":529,"activeCount":54},[],{"trials":531,"activeCount":54},[],{"intervention":523,"totalTrials":9,"cells":533},{"EARLY_PHASE1":534,"PHASE1":536,"PHASE2":542,"PHASE3":544,"PHASE4":546,"NA":548},{"trials":535,"activeCount":54},[],{"trials":537,"activeCount":54},[538],{"nctId":513,"briefTitle":514,"status":73,"phases":539,"primaryCompletion":516,"completion":516,"start":517,"enrollment":518,"conditions":540,"interventions":541},[43],[520,521],[506,523],{"trials":543,"activeCount":54},[],{"trials":545,"activeCount":54},[],{"trials":547,"activeCount":54},[],{"trials":549,"activeCount":54},[],{"intervention":551,"totalTrials":9,"cells":552},"bacitracin\u002Fxeroform",{"EARLY_PHASE1":553,"PHASE1":555,"PHASE2":567,"PHASE3":569,"PHASE4":571,"NA":573},{"trials":554,"activeCount":54},[],{"trials":556,"activeCount":54},[557],{"nctId":558,"briefTitle":559,"status":126,"phases":560,"primaryCompletion":561,"completion":561,"start":562,"enrollment":54,"conditions":563,"interventions":565},"NCT00479193","Polymem vs. Bacitracin\u002FXeroform in Treating Burn Wounds",[43],"2008-12","2006-10",[564],"Burns",[551,566],"Polymem",{"trials":568,"activeCount":54},[],{"trials":570,"activeCount":54},[],{"trials":572,"activeCount":54},[],{"trials":574,"activeCount":54},[],{"intervention":566,"totalTrials":9,"cells":576},{"EARLY_PHASE1":577,"PHASE1":579,"PHASE2":585,"PHASE3":587,"PHASE4":589,"NA":591},{"trials":578,"activeCount":54},[],{"trials":580,"activeCount":54},[581],{"nctId":558,"briefTitle":559,"status":126,"phases":582,"primaryCompletion":561,"completion":561,"start":562,"enrollment":54,"conditions":583,"interventions":584},[43],[564],[551,566],{"trials":586,"activeCount":54},[],{"trials":588,"activeCount":54},[],{"trials":590,"activeCount":54},[],{"trials":592,"activeCount":54},[],{"intervention":594,"totalTrials":9,"cells":595},"Indomethacin",{"EARLY_PHASE1":596,"PHASE1":607,"PHASE2":609,"PHASE3":611,"PHASE4":613,"NA":615},{"trials":597,"activeCount":54},[598],{"nctId":599,"briefTitle":600,"status":126,"phases":601,"primaryCompletion":602,"completion":602,"start":603,"enrollment":54,"conditions":604,"interventions":606},"NCT01869361","Indomethacin for Tocolysis of Preterm Labor",[42],"2021-11-23","2020-08-01",[605],"Preterm Labor",[594],{"trials":608,"activeCount":54},[],{"trials":610,"activeCount":54},[],{"trials":612,"activeCount":54},[],{"trials":614,"activeCount":54},[],{"trials":616,"activeCount":54},[],{"intervention":618,"totalTrials":9,"cells":619},"ipratropium",{"EARLY_PHASE1":620,"PHASE1":622,"PHASE2":624,"PHASE3":626,"PHASE4":628,"NA":630},{"trials":621,"activeCount":54},[],{"trials":623,"activeCount":54},[],{"trials":625,"activeCount":54},[],{"trials":627,"activeCount":54},[],{"trials":629,"activeCount":54},[],{"trials":631,"activeCount":54},[632],{"nctId":633,"briefTitle":634,"status":73,"phases":635,"primaryCompletion":636,"completion":561,"start":637,"enrollment":638,"conditions":639,"interventions":641},"NCT00583778","A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation",[47],"2008-11","2004-08",141,[640],"Asthma",[618],{"intervention":643,"totalTrials":9,"cells":644},"erythromycin and metronidazole",{"EARLY_PHASE1":645,"PHASE1":647,"PHASE2":649,"PHASE3":651,"PHASE4":653,"NA":655},{"trials":646,"activeCount":54},[],{"trials":648,"activeCount":54},[],{"trials":650,"activeCount":54},[],{"trials":652,"activeCount":54},[],{"trials":654,"activeCount":54},[],{"trials":656,"activeCount":54},[657],{"nctId":658,"briefTitle":659,"status":451,"phases":660,"primaryCompletion":661,"completion":661,"start":412,"enrollment":662,"conditions":663,"interventions":665},"NCT00589329","Antibiotics and the Prolongation of Pregnancy in Preterm Labor With an Advanced Cervical Exam",[47],"2012-10",20,[664],"Length of Pregnancy Prolongation in Hours",[643],{"intervention":667,"totalTrials":9,"cells":668},"either fentanyl or morphine",{"EARLY_PHASE1":669,"PHASE1":671,"PHASE2":673,"PHASE3":675,"PHASE4":677,"NA":679},{"trials":670,"activeCount":54},[],{"trials":672,"activeCount":54},[],{"trials":674,"activeCount":54},[],{"trials":676,"activeCount":54},[],{"trials":678,"activeCount":54},[],{"trials":680,"activeCount":54},[681],{"nctId":682,"briefTitle":683,"status":73,"phases":684,"primaryCompletion":561,"completion":561,"start":685,"enrollment":686,"conditions":687,"interventions":690},"NCT00580489","Lifeflight: Fentanyl Versus Morphine",[47],"2006-08",204,[688,689],"Pain Relief","Adverse Events",[667],{"intervention":692,"totalTrials":9,"cells":693},"buprenorphine\u002Fnaloxone",{"EARLY_PHASE1":694,"PHASE1":696,"PHASE2":698,"PHASE3":700,"PHASE4":702,"NA":704},{"trials":695,"activeCount":54},[],{"trials":697,"activeCount":54},[],{"trials":699,"activeCount":54},[],{"trials":701,"activeCount":54},[],{"trials":703,"activeCount":54},[],{"trials":705,"activeCount":54},[706],{"nctId":707,"briefTitle":708,"status":73,"phases":709,"primaryCompletion":710,"completion":710,"start":711,"enrollment":712,"conditions":713,"interventions":717},"NCT03976258","Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV",[],"2022-12-31","2017-07-14",190,[714,715,716],"HIV Infection","Opioid-use Disorder","Cardiovascular Diseases",[692,718,719,720],"Methadone","Naltrexone","Heroin",{"intervention":718,"totalTrials":9,"cells":722},{"EARLY_PHASE1":723,"PHASE1":725,"PHASE2":727,"PHASE3":729,"PHASE4":731,"NA":733},{"trials":724,"activeCount":54},[],{"trials":726,"activeCount":54},[],{"trials":728,"activeCount":54},[],{"trials":730,"activeCount":54},[],{"trials":732,"activeCount":54},[],{"trials":734,"activeCount":54},[735],{"nctId":707,"briefTitle":708,"status":73,"phases":736,"primaryCompletion":710,"completion":710,"start":711,"enrollment":712,"conditions":737,"interventions":738},[],[714,715,716],[692,718,719,720],{"intervention":719,"totalTrials":9,"cells":740},{"EARLY_PHASE1":741,"PHASE1":743,"PHASE2":745,"PHASE3":747,"PHASE4":749,"NA":751},{"trials":742,"activeCount":54},[],{"trials":744,"activeCount":54},[],{"trials":746,"activeCount":54},[],{"trials":748,"activeCount":54},[],{"trials":750,"activeCount":54},[],{"trials":752,"activeCount":54},[753],{"nctId":707,"briefTitle":708,"status":73,"phases":754,"primaryCompletion":710,"completion":710,"start":711,"enrollment":712,"conditions":755,"interventions":756},[],[714,715,716],[692,718,719,720],{"intervention":720,"totalTrials":9,"cells":758},{"EARLY_PHASE1":759,"PHASE1":761,"PHASE2":763,"PHASE3":765,"PHASE4":767,"NA":769},{"trials":760,"activeCount":54},[],{"trials":762,"activeCount":54},[],{"trials":764,"activeCount":54},[],{"trials":766,"activeCount":54},[],{"trials":768,"activeCount":54},[],{"trials":770,"activeCount":54},[771],{"nctId":707,"briefTitle":708,"status":73,"phases":772,"primaryCompletion":710,"completion":710,"start":711,"enrollment":712,"conditions":773,"interventions":774},[],[714,715,716],[692,718,719,720],{"intervention":776,"totalTrials":9,"cells":777},"TAP Block",{"EARLY_PHASE1":778,"PHASE1":780,"PHASE2":782,"PHASE3":784,"PHASE4":786,"NA":788},{"trials":779,"activeCount":54},[],{"trials":781,"activeCount":54},[],{"trials":783,"activeCount":54},[],{"trials":785,"activeCount":54},[],{"trials":787,"activeCount":54},[],{"trials":789,"activeCount":54},[790],{"nctId":791,"briefTitle":792,"status":73,"phases":793,"primaryCompletion":794,"completion":795,"start":796,"enrollment":797,"conditions":798,"interventions":801},"NCT01479270","Transversus Abdominal Plane Block at Total Laparoscopic Hysterectomy: Effect on Quality of Recovery",[47],"2011-09","2012-01","2011-05",56,[799,800],"Pain, Postoperative","Anesthesia",[776],{"intervention":803,"totalTrials":9,"cells":804},"Propranolol LA",{"EARLY_PHASE1":805,"PHASE1":807,"PHASE2":809,"PHASE3":811,"PHASE4":813,"NA":815},{"trials":806,"activeCount":54},[],{"trials":808,"activeCount":54},[],{"trials":810,"activeCount":54},[],{"trials":812,"activeCount":54},[],{"trials":814,"activeCount":54},[],{"trials":816,"activeCount":54},[817],{"nctId":818,"briefTitle":819,"status":73,"phases":820,"primaryCompletion":561,"completion":561,"start":821,"enrollment":822,"conditions":823,"interventions":826},"NCT00588965","Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects",[47],"2007-08",36,[824,825],"Long QT Syndrome","Cardiac Repolarization",[803],{"intervention":828,"totalTrials":9,"cells":829},"Lansoprazole",{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":834,"PHASE3":836,"PHASE4":838,"NA":840},{"trials":831,"activeCount":54},[],{"trials":833,"activeCount":54},[],{"trials":835,"activeCount":54},[],{"trials":837,"activeCount":54},[],{"trials":839,"activeCount":54},[],{"trials":841,"activeCount":54},[842],{"nctId":843,"briefTitle":844,"status":126,"phases":845,"primaryCompletion":846,"completion":846,"start":847,"enrollment":54,"conditions":848,"interventions":850},"NCT00211614","Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea",[47],"2006-09","2006-07",[28,849],"Gastroesophageal Reflux",[828],{"intervention":852,"totalTrials":9,"cells":853},"Lactated Ringer's",{"EARLY_PHASE1":854,"PHASE1":856,"PHASE2":858,"PHASE3":860,"PHASE4":862,"NA":864},{"trials":855,"activeCount":54},[],{"trials":857,"activeCount":54},[],{"trials":859,"activeCount":54},[],{"trials":861,"activeCount":54},[],{"trials":863,"activeCount":54},[],{"trials":865,"activeCount":54},[866],{"nctId":867,"briefTitle":868,"status":73,"phases":869,"primaryCompletion":870,"completion":870,"start":871,"enrollment":872,"conditions":873,"interventions":875},"NCT02565485","Pulse Pressure and Post-epidural Fetal Heart Rate Changes",[47],"2016-11-01","2015-09-01",276,[874],"Fetus or Neonate Affected by Maternal Epidural Anesthesia During Labor and Delivery",[852]]